News

Japan-based Innovation Network Corporation led the funding. PRI-724, which is currently in clinical trials for the treatment of solid tumors and leukemia, is an antiproliferative small molecule that

An orally available Janus kinase (JAK) inhibitor, Baricitinib is being studied to treat certain autoimmune conditions, including RA. Clinical improvements which were observed at 24-week continued at the

The study is intended to assess safety, tolerability and efficacy in patients suffering from one of the most serious manifestations of systemic lupus erythematosus (SLE or lupus) that

The drugs are intended to clear the accumulated beta-amyloid from the brain resulting in a halt or reverse the series of Alzheimer’s disease. The company has recognized a

Kitasato Daiichi Sankyo Vaccine and JICA have provided technical assistance to Vietnam’s Center for Research and Production of Vaccines and Biologicals (POLYVAC) to produce the measles vaccine from

Marking expansion of Avantor’s global pharmaceutical manufacturing base, the Indian Food and Drug Administration approved and certified plant will produce and package the company’s Macron Fine Chemicals brand

NeuroVive Pharmaceutical CEO Mikael Brönnegård said that the partnership with Isomerase Therapeutics for the molecules recently acquired from Biotica marks the beginning of expansion of its product range.

Approved after conducting a priority review, XGEVA becomes the first FDA-passed treatment for this rare disease that cannot be taken away through surgery or planned surgical resection may

Under the terms of the agreement, BD’s BD Biosciences Custom Technology Team will perform sample analysis on Amarantus’ LymPro Test for Alzheimer’s disease. Amarantus president and CEO Gerald